<DOC>
	<DOCNO>NCT02467738</DOCNO>
	<brief_summary>This pilot clinical trial study cesium Cs 131 brachytherapy treat patient head neck cancer come back ( recurrent ) remove surgery . Brachytherapy , also know internal radiation therapy , use radioactive material place directly near tumor kill tumor cell . Radioactive drug , cesium Cs 131 , may carry radiation directly tumor cell harm normal cell . Permanently implant cesium Cs 131 wound bed surgery may help treat microscopic cancer cell may tissue surgical removal tumor .</brief_summary>
	<brief_title>Surgical Resection Intraoperative Cesium-131 Brachytherapy Head Neck Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I. Assess impact cesium 131 ( cesium Cs 131 ) recurrence rate , disease free survival survival . SECONDARY OBJECTIVES : I. Assess complication associate cesium 131 treatment subject head neck cancer . OUTLINE : Patients undergo brachytherapy use cesium Cs 131 surgical resection . After completion study treatment , patient follow 30 day every 3 month 24 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>1 . Diagnosis : Subjects diagnosis recurrent head neck cancer 2 . Based clinical radiographic evidence tumor need deem resectable preoperatively 3 . Age : Subjects must ≥ 18 year age ≤ 90 year old 4 . Informed Consent : All subject must able comprehend sign write informed consent document 1 . Subjects pregnant may become pregnant 2 . Unresectable tumor 3 . Other severe acute chronic medical psychiatric condition may increase risk associate study participation , judgment investigator would make subject inappropriate entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>